Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2014
03/06/2014US20140065149 Methods for Treating Melanoma
03/06/2014US20140065148 Treatment methods using antibodies to aminophospholipids
03/06/2014US20140065147 Use of Cytokine Expression to Predict Skin Inflammation; Methods of Treatment
03/06/2014US20140065145 Method for producing solid formulations comprising immunoglobulin single variable domains
03/06/2014US20140065142 Multivalent and Monovalent Multispecific Complexes and Their Uses
03/06/2014US20140065141 Csf-1r inhibitors for treatment of brain tumors
03/06/2014US20140065139 Induction of Tumor Hypoxia for Cancer Therapy
03/06/2014US20140065136 Dioxino- and oxazin-[2,3-d]pyrimidine pi3k inhibitor compounds and methods of use
03/06/2014US20140065135 Methods of using anti-pd-l1 antibodies and their use to enhance t-cell function to treat tumor immunity
03/06/2014US20140065134 Combination therapy of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxity (adcc)
03/06/2014US20140065133 Jak/stat inhibitors and mapk/erk inhibitors for rsv infection
03/06/2014US20140065132 Diagnosis and treatment of autism spectrum disorder
03/06/2014US20140065105 Simian Adenovirus Nucleic Acid and Amino Acid Sequences, Vectors Containing Same, and Methods of Use
03/06/2014US20140065102 Methods for the treatment of hepatitis b and hepatitis d infections
03/06/2014US20140065100 Compositions and Methods for Cancer Immunotherapy
03/06/2014US20140065098 Method to augment immune system in response to disease or injury
03/06/2014US20140065063 Therapeutic use of anti-cs1 antibodies
03/05/2014EP2703491A1 Protein and nucleic acid delivery vehicles, components and mechanisms thereof
03/05/2014EP2703488A1 Composition for predicting sensitivity to trastuzumab therapy in breast cancer patients and method using same
03/05/2014EP2703486A1 Anti-b7-h3 antibody
03/05/2014EP2703483A1 PCSK9 peptide vaccine
03/05/2014EP2703482A1 VSV-HIV viral particles lacking reverse transcriptase functionality and therapeutic applications thereof
03/05/2014EP2703415A1 Novel compositions and methods for treating IgE-mediated disorders
03/05/2014EP2703414A1 Antigen binding proteins capable of binding thymic stromal lymphopoietin
03/05/2014EP2703011A2 Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease
03/05/2014EP2703010A2 Uses and compositions for treatment of rheumatoid arthritis
03/05/2014EP2703009A1 Combination treatments involving antibodies to human PCSK9
03/05/2014EP2703008A1 Human antibodies to PCSK9 for use in methods of treating particular groups of subjects
03/05/2014EP2703007A1 Antibodies with decreased deamidation profiles
03/05/2014EP2703001A1 Tumor vaccination
03/05/2014EP2702997A1 Method and composition for enhancing target cells uptake of therapeutic agents
03/05/2014EP2702412A1 Anti-human receptor-type protein tyrosine phosphatase antibody
03/05/2014EP2702164A1 A method for reducing heterogeneity of antibodies and a process of producing the antibodies thereof
03/05/2014EP2702159A1 Modified sendai virus vaccine and imaging vector
03/05/2014EP2702149A1 Natural derivative of the lactobacilus johnsonii strain cncm i-1225, deficient in d-lactic acid production and with a further improved immune profile
03/05/2014EP2702078A2 Anti-cd40 antibodies and methods of use
03/05/2014EP2702075A1 Neutralizing antibodies to nipah and hendra virus
03/05/2014EP2702074A1 Novel immunoconjugates
03/05/2014EP2702030A1 Compositions and methods
03/05/2014EP2701745A1 Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
03/05/2014EP2701743A2 Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies
03/05/2014EP2701742A1 Compositions and method for treating autoimmune diseases
03/05/2014EP2701741A1 Dosage regimen for administering a cd19xcd3 bispecific antibody to patients at risk for potential adverse effects
03/05/2014EP2701740A1 Microparticle and/or nanoparticle vaccine for prophylactic and/or therapeutic application
03/05/2014EP2701739A1 Tolerogenic synthetic nanocarriers to reduce antibody responses
03/05/2014EP2701738A2 Tolerogenic synthetic nanocarriers for inducing regulatory b cells
03/05/2014EP2701737A1 Tolerogenic synthetic nanocarriers for allergy therapy
03/05/2014EP2701736A1 Truncated hiv envelope proteins (env), methods and compositions related thereto
03/05/2014EP2701735A2 Liquid vaccine preparations
03/05/2014EP2701734A2 Liposomal formulations
03/05/2014EP2701722A2 Human myeloid derived suppressor cell cancer markers
03/05/2014EP2701706A2 Tolerogenic synthetic nanocarriers
03/05/2014EP2701705A2 Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
03/05/2014CN103620050A Fermentation process
03/05/2014CN103620033A SEMA5B peptides and vaccines including the same
03/05/2014CN103619883A Binding proteins to inhibitors of coagulation factors
03/05/2014CN103619879A Anti-ngf compositions and use thereof
03/05/2014CN103619877A Modified variable domain molecules and methods for producing and using them b
03/05/2014CN103619875A Engineering of immunoglobulin domains
03/05/2014CN103619874A Soluble integrin [alpha]4 mutant
03/05/2014CN103619871A Compositions relating to a mutant clostridium difficile toxin and methods thereof
03/05/2014CN103619870A Epitope and its use of hepatitis b virus surface antigen
03/05/2014CN103619353A Fc receptor binding proteins
03/05/2014CN103619352A Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglin
03/05/2014CN103619351A Anti-CCL25 and anti-CCR9 antibodies for the prevention and treatment of cancer and cancer cell migration
03/05/2014CN103619350A A method of vaccination comprising a histone deacetylase inhibitor
03/05/2014CN103619349A Inactivated dengue virus vaccine
03/05/2014CN103619325A Methods for producing liposomes
03/05/2014CN103614346A Method for harvesting viruses by utilization of harvest solution with high osmotic pressure
03/05/2014CN103614345A Influenza virus vaccine strain
03/05/2014CN103614331A Preparation method and application of recombinant lactococcus lactis capable of displaying peanut allergen on surface
03/05/2014CN103613680A Alcohol-precipitated panax japonicus polysaccharide, and preparation method and application thereof
03/05/2014CN103613675A Herba epimedii polysaccharide and components thereof as well as use of herba epimedii polysaccharide and components thereof as vaccine adjuvants
03/05/2014CN103611158A Immune globulin injection for dogs and cats
03/05/2014CN103611157A Panax japonicus saponin as well as preparation method and application thereof
03/05/2014CN103611156A Avian pentavalent vaccine and preparation method thereof
03/05/2014CN103610641A Two-phase oil emulsion adjuvant for veterinary vaccines, and production method thereof
03/05/2014CN103045630B Encephalitis virus protein and encoding gene and application thereof
03/05/2014CN103014044B Encephalitis virus protein as well as coding gene and application thereof
03/05/2014CN102864157B Immune protective antigen of haemophilus parasuis
03/05/2014CN102702351B Humanized EV71 antivirus neutralizing antibody EV71FabL6 and preparation method and application thereof
03/05/2014CN102617712B Polypeptide for effectively restraining activity of influenza virus polymerase
03/05/2014CN102580115B Tuberculosis mucosa gene vaccine assembled by using chitosan oligosaccharide delivery system and preparation and application of tuberculosis mucosa gene vaccine
03/05/2014CN101868474B Poxviral oncolytic vectors
03/05/2014CN101795713B Conjugate purification
03/05/2014CN101730541B Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
03/05/2014CN101680036B Raccoon poxvirus expressing rabies glycoproteins
03/05/2014CN101631802B Anti-human Dlk-1 antibody showing anti-tumor activity in vivo
03/05/2014CN101330929B Inhibitor of transplanted islet dysfunction in islet transplantation
03/04/2014US8664470 Mouse model of retinal degeneration
03/04/2014US8664368 Fully human monoclonal antibody to VEGF, preparation method and use thereof
03/04/2014US8664363 Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
03/04/2014US8664362 Humanized and chimeric anti-properdin antibodies
03/04/2014US8664360 BSL3 polypeptides
03/04/2014US8663968 Simian T-cell lymphotropic virus
03/04/2014US8663951 Method of producing virus-like particles of picornavirus using a small-ubiquitin-related fusion protein expression system
03/04/2014US8663950 Production of a monoclonal antibody therapeutic against west nile virus in plants
03/04/2014US8663926 Detection of anthrax pathogenicity factors
03/04/2014US8663657 Nucleic acid constructs
03/04/2014US8663656 Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 1823